News
-
-
-
-
-
PRESS RELEASE
HBM Healthcare Investments expects to report a net profit of CHF 19 million for the 2024/2025 financial year
HBM Healthcare Investments AG expects a net profit of CHF 19 million for the 2024/2025 financial year, with positive performance and value-enhancing transactions in the healthcare sector -
-
-
PRESS RELEASE
Sanofi to acquire DR-0201, a clinical-stage program of HBM portfolio company Dren Bio, for upfront amount of USD 600 million, plus potential milestones
Sanofi to acquire DR-0201, a clinical-stage program of HBM portfolio company Dren Bio for $600 million upfront plus potential milestones, enhancing HBM Healthcare Investments -
-